$CHE
CHEMED CORP

2021 Q4 Form 10-K Financial Statement

#000156276222000060 Filed on February 28, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $541.0M $2.139B $533.3M
YoY Change 1.44% 2.87% 2.11%
Cost Of Revenue $336.3M $1.369B $335.0M
YoY Change 0.4% -0.63% -3.57%
Gross Profit $204.7M $769.8M $198.2M
YoY Change 3.25% 9.75% 13.26%
Gross Profit Margin 37.83% 35.98% 37.16%
Selling, General & Admin $89.87M $366.7M $80.60M
YoY Change 11.51% 11.06% 1.26%
% of Gross Profit 43.92% 47.64% 40.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $14.35M $59.05M $14.40M
YoY Change -0.35% 4.36% 2.13%
% of Gross Profit 7.01% 7.67% 7.27%
Operating Expenses $104.2M $366.7M $94.90M
YoY Change 9.83% 11.06% 1.28%
Operating Profit $100.4M $343.0M $103.3M
YoY Change -2.78% -11.97% 27.06%
Interest Expense -$436.0K $1.868M -$200.0K
YoY Change 118.0% -20.68% -86.67%
% of Operating Profit -0.43% 0.54% -0.19%
Other Income/Expense, Net -$6.000K $9.144M $0.00
YoY Change 5.53%
Pretax Income $96.13M $350.3M $145.8M
YoY Change -34.07% -11.53% 83.17%
Income Tax $21.50M $81.76M $32.10M
% Of Pretax Income 22.37% 23.34% 22.02%
Net Earnings $74.63M $268.6M $113.8M
YoY Change -34.42% -15.94% 73.48%
Net Earnings / Revenue 13.79% 12.55% 21.34%
Basic Earnings Per Share $17.14
Diluted Earnings Per Share $4.814M $16.85 $6.982M
COMMON SHARES
Basic Shares Outstanding 15.67M
Diluted Shares Outstanding 15.94M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.90M $32.90M $162.7M
YoY Change -79.78% -79.78% 2524.19%
Cash & Equivalents $32.90M $32.90M $162.7M
Short-Term Investments
Other Short-Term Assets $50.07M $50.07M $32.80M
YoY Change 52.64% 52.64% -1.2%
Inventory $10.11M $10.11M $7.095M
Prepaid Expenses
Receivables $137.2M $137.2M $126.9M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $230.3M $230.3M $329.4M
YoY Change -30.09% -30.09% 72.76%
LONG-TERM ASSETS
Property, Plant & Equipment $193.7M $318.7M $187.8M
YoY Change 3.12% 2.39% 6.86%
Goodwill $578.6M $578.6M
YoY Change 0.0% 0.21%
Intangibles $108.1M $118.1M
YoY Change -8.46% -6.56%
Long-Term Investments $98.88M $98.88M $88.80M
YoY Change 11.36% 11.36% 14.73%
Other Assets $8.138M $8.138M $8.759M
YoY Change -7.09% -7.52% -3.19%
Total Long-Term Assets $1.112B $1.112B $1.106B
YoY Change 0.63% 0.63% 2.59%
TOTAL ASSETS
Total Short-Term Assets $230.3M $230.3M $329.4M
Total Long-Term Assets $1.112B $1.112B $1.106B
Total Assets $1.343B $1.343B $1.435B
YoY Change -6.42% -6.42% 13.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $73.02M $61.12M $54.23M
YoY Change 34.65% 12.77% 6.13%
Accrued Expenses $190.3M $190.3M $192.8M
YoY Change -1.3% -1.3% 15.17%
Deferred Revenue
YoY Change
Short-Term Debt $11.90M $11.90M $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $302.4M $302.4M $299.1M
YoY Change 1.1% 1.1% 14.07%
LONG-TERM LIABILITIES
Long-Term Debt $185.0M $185.0M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $9.642M $208.9M $26.27M
YoY Change -63.3% -2.35% 233.29%
Total Long-Term Liabilities $194.6M $393.9M $26.27M
YoY Change 640.84% 84.14% -73.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $302.4M $302.4M $299.1M
Total Long-Term Liabilities $194.6M $393.9M $26.27M
Total Liabilities $719.5M $719.5M $533.7M
YoY Change 34.8% 34.8% -1.48%
SHAREHOLDERS EQUITY
Retained Earnings $1.970B $1.724B
YoY Change 14.3% 20.9%
Common Stock $1.081B $997.7M
YoY Change 8.34% 11.29%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.430B $1.823B
YoY Change 33.33% 14.06%
Treasury Stock Shares $21.60M $20.35M
Shareholders Equity $623.3M $623.3M $901.2M
YoY Change
Total Liabilities & Shareholders Equity $1.343B $1.343B $1.435B
YoY Change -6.42% -6.42% 13.14%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $74.63M $268.6M $113.8M
YoY Change -34.42% -15.94% 73.48%
Depreciation, Depletion And Amortization $14.35M $59.05M $14.40M
YoY Change -0.35% 4.36% 2.13%
Cash From Operating Activities $63.57M $308.6M $86.90M
YoY Change -26.85% -36.93% 36.64%
INVESTING ACTIVITIES
Capital Expenditures -$14.20M $58.68M -$16.10M
YoY Change -11.78% -0.27% 21.97%
Acquisitions
YoY Change
Other Investing Activities $158.0K -$918.0K $200.0K
YoY Change -21.0% 5.4% 0.0%
Cash From Investing Activities -$14.04M -$57.76M -$16.00M
YoY Change -12.22% -6.18% 22.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $576.0M
YoY Change 228.05%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -45.37M -380.6M -21.00M
YoY Change 116.06% 40.34% -60.75%
NET CHANGE
Cash From Operating Activities 63.57M 308.6M 86.90M
Cash From Investing Activities -14.04M -57.76M -16.00M
Cash From Financing Activities -45.37M -380.6M -21.00M
Net Change In Cash 4.152M -129.8M 49.90M
YoY Change -91.68% -182.92% -1763.33%
FREE CASH FLOW
Cash From Operating Activities $63.57M $308.6M $86.90M
Capital Expenditures -$14.20M $58.68M -$16.10M
Free Cash Flow $77.77M $249.9M $103.0M
YoY Change -24.49% -41.94% 34.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 che Stock Options Forfeiture Rate
StockOptionsForfeitureRate
CY2020 che Stock Options Forfeiture Rate
StockOptionsForfeitureRate
CY2021 che Stock Options Forfeiture Rate
StockOptionsForfeitureRate
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0000019584
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
1-8351
CY2021 dei Entity Registrant Name
EntityRegistrantName
CHEMED CORPORATION
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 2600
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
255 East Fifth Street
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Cincinnati
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-0791746
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45202-4726
CY2021 dei City Area Code
CityAreaCode
513
CY2021 dei Local Phone Number
LocalPhoneNumber
762-6690
CY2021 dei Security12b Title
Security12bTitle
Capital Stock – Par Value $1 Per Share
CY2021 dei Trading Symbol
TradingSymbol
CHE
CY2021 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
7331967357
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14988567
CY2021 dei Auditor Firm
AuditorFirmId
238
CY2021 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2021 dei Auditor Location
AuditorLocation
Cincinnati, Ohio
CY2021 us-gaap Revenues
Revenues
2139261000
CY2020 us-gaap Revenues
Revenues
2079583000
CY2019 us-gaap Revenues
Revenues
1938555000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1369458000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1378197000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1321126000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
366727000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
330218000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
305712000
CY2021 us-gaap Depreciation
Depreciation
49011000
CY2020 us-gaap Depreciation
Depreciation
46596000
CY2019 us-gaap Depreciation
Depreciation
40870000
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
10040000
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
9987000
CY2019 us-gaap Adjustment For Amortization
AdjustmentForAmortization
4335000
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-987000
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
75095000
CY2019 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-9132000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
1796223000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
1689903000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
1681175000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
343038000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
389680000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
257380000
CY2021 us-gaap Interest Expense
InterestExpense
1868000
CY2020 us-gaap Interest Expense
InterestExpense
2355000
CY2019 us-gaap Interest Expense
InterestExpense
4535000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9144000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8665000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8764000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
350314000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
395990000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
261609000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
81764000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76524000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41686000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
268550000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
319466000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
219923000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
17.14
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
20.02
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
13.77
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15671000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15955000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15969000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
16.85
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
19.48
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
13.31
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15938000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16398000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16527000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32895000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162675000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
137217000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126853000
CY2021Q4 us-gaap Inventory Net
InventoryNet
10109000
CY2020Q4 us-gaap Inventory Net
InventoryNet
7095000
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
17377000
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
6603000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
32688000
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
26177000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
230286000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
329403000
CY2021Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
98884000
CY2020Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
88811000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193680000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
187820000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
125048000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
123448000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
108096000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
118085000
CY2021Q4 us-gaap Goodwill
Goodwill
578591000
CY2020Q4 us-gaap Goodwill
Goodwill
578585000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8138000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8759000
CY2021Q4 us-gaap Assets
Assets
1342723000
CY2020Q4 us-gaap Assets
Assets
1434911000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
73024000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
54234000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
41000
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9464000
CY2021Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
55918000
CY2020Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
54703000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
95598000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
91282000
CY2021Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
872000
CY2020Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
10632000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37913000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
36200000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39033000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
42593000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
302399000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
299108000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
23183000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
20664000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
185000000
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
98597000
CY2020Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
88456000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
100629000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
99210000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9642000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
26273000
CY2021Q4 us-gaap Liabilities
Liabilities
719450000
CY2020Q4 us-gaap Liabilities
Liabilities
533711000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36513857
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36258638
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
36514000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
36259000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1044341000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
961404000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1970311000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1723777000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
21601325
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
20351562
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2430094000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1822579000
CY2021Q4 che Deferred Compensation Payable In Company Stock
DeferredCompensationPayableInCompanyStock
2201000
CY2020Q4 che Deferred Compensation Payable In Company Stock
DeferredCompensationPayableInCompanyStock
2339000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
623273000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
901200000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1342723000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1434911000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
268550000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
319466000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
219923000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
59051000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
56583000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
45205000
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
22502000
CY2020 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
18422000
CY2019 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
14831000
CY2021 che Deferred Payroll Taxes
DeferredPayrollTaxes
-18175000
CY2020 che Deferred Payroll Taxes
DeferredPayrollTaxes
36350000
CY2021 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
9440000
CY2020 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
2684000
CY2019 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
6000000
CY2021 che Noncash Long Term Incentive Compensation
NoncashLongTermIncentiveCompensation
7745000
CY2020 che Noncash Long Term Incentive Compensation
NoncashLongTermIncentiveCompensation
7208000
CY2019 che Noncash Long Term Incentive Compensation
NoncashLongTermIncentiveCompensation
5740000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2400000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1433000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2770000
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1173000
CY2020 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1171000
CY2019 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
767000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
306000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
306000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
306000
CY2019 che Loss On Sale Of Transportation Equipment
LossOnSaleOfTransportationEquipment
2266000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8431000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-12773000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19247000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3014000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-367000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1757000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6511000
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3027000
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3491000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9832000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19096000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28417000
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-20401000
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
13525000
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
161000
CY2021 che Increase Decrease In Lease Assets And Liabilities
IncreaseDecreaseInLeaseAssetsAndLiabilities
44000
CY2020 che Increase Decrease In Lease Assets And Liabilities
IncreaseDecreaseInLeaseAssetsAndLiabilities
-1206000
CY2019 che Increase Decrease In Lease Assets And Liabilities
IncreaseDecreaseInLeaseAssetsAndLiabilities
-3108000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
10305000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
11834000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
11963000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
12074000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
12323000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
12354000
CY2021 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1285000
CY2020 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1237000
CY2019 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1399000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
308597000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
489289000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
301249000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58675000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58831000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
53022000
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3600000
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
138010000
CY2021 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-918000
CY2020 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-871000
CY2019 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-272000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57757000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-61560000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-190760000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
576042000
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
175594000
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
92631000
CY2021 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
210300000
CY2020 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
174900000
CY2019 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
482900000
CY2021 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
25300000
CY2020 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
264900000
CY2019 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
482100000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
35848000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50382000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
34380000
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22016000
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
21079000
CY2019 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
19788000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15129000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
25328000
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
28474000
CY2021 us-gaap Increase Decrease In Outstanding Checks Financing Activities
IncreaseDecreaseInOutstandingChecksFinancingActivities
11884000
CY2020 us-gaap Increase Decrease In Outstanding Checks Financing Activities
IncreaseDecreaseInOutstandingChecksFinancingActivities
-9849000
CY2019 us-gaap Increase Decrease In Outstanding Checks Financing Activities
IncreaseDecreaseInOutstandingChecksFinancingActivities
-3927000
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-165000
CY2020 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
256000
CY2019 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
478000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-380620000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-271212000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-109162000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-129780000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
156517000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1327000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162675000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6158000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4831000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32895000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162675000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6158000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
591334000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
219923000
CY2019 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.24
CY2019 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19788000
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
27245000
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
92631000
CY2019 us-gaap Stockholders Equity Other
StockholdersEquityOther
525000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
726608000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
319466000
CY2020 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.32
CY2020 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
21079000
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
51855000
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
175594000
CY2020 us-gaap Stockholders Equity Other
StockholdersEquityOther
-56000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
901200000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
268550000
CY2021 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.40
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
22016000
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
52139000
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
576483000
CY2021 us-gaap Stockholders Equity Other
StockholdersEquityOther
-117000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
623273000
CY2021 us-gaap Nature Of Operations
NatureOfOperations
NATURE OF OPERATIONS We operate through our two wholly-owned subsidiaries: VITAS Healthcare Corporation (“VITAS”) and Roto-Rooter Group, Inc. (“Roto-Rooter”). VITAS focuses on hospice care that helps make terminally ill patients' final days as comfortable as possible. Through its team of doctors, nurses, home health aides, social workers, clergy and volunteers, VITAS provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Roto-Rooter provides plumbing, drain cleaning and water restoration services to both residential and commercial customers. Through its network of company-owned branches, independent contractors and franchisees, Roto-Rooter offers plumbing, drain cleaning service and water restoration to approximately 90% of the U.S. population.
CY2021 che Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2
CY2021Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
46200000
CY2020 che Deferred Payroll Taxes
DeferredPayrollTaxes
36400000
CY2021 che Deferred Payroll Taxes Paid
DeferredPayrollTaxesPaid
18200000
CY2021 che Deferred Payroll Taxes Short Term Liability
DeferredPayrollTaxesShortTermLiability
18200000
CY2021 che Pandemic Expenses Incurred
PandemicExpensesIncurred
14000000.0
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
CONCENTRATION OF RISK As of December 31, 2021, and 2020, approximately 73% and 74%, respectively, of VITAS’ total accounts receivable balance were from Medicare and 21% and 20%, respectively, of VITAS’ total accounts receivable balance were due from various state Medicaid or managed Medicaid programs. Combined accounts receivable from Medicare, Medicaid, and managed Medicaid represent approximately 80% of the consolidated net accounts receivable in the accompanying consolidated balance sheets as of December 31, 2021. VITAS has a pharmacy services contract with one service provider for specified pharmacy services related to its hospice operations. A large majority of VITAS’ pharmaceutical purchases are from this vendor. The pharmaceuticals purchased by VITAS are available through many providers in the United States. However, a disruption from VITAS’ main service provider could adversely impact VITAS’ operations, including temporary logistical challenges and increased cost associated with getting medication to our patients.
CY2019Q4 us-gaap Goodwill
Goodwill
577367000
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1193000
CY2020 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
25000
CY2020Q4 us-gaap Goodwill
Goodwill
578585000
CY2021 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
6000
CY2021Q4 us-gaap Goodwill
Goodwill
578591000
CY2021 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
up to 5 years
CY2021Q4 che Number Of Cloud Computing Arrangements
NumberOfCloudComputingArrangements
3
CY2021 us-gaap Advertising Expense
AdvertisingExpense
62100000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
54400000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
49500000
CY2021 che Historical Claims Data Period Of Time
HistoricalClaimsDataPeriodOfTime
P10Y
CY2021 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Period Increase Decrease
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease
-6332000
CY2020 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Period Increase Decrease
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease
-4578000
CY2019 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Period Increase Decrease
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease
-1664000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.233
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.193
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.159
CY2021 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
9900000
CY2020 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
26100000
CY2019 us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
24200000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
ESTIMATES The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1334667000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1319851000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1281184000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1289433000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1261246000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1368489000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
185000000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
185000000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1403000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
2028000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
4125000
CY2021 che Stock Options Number Of Stock Incentive Plans
StockOptionsNumberOfStockIncentivePlans
3
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5100000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P2Y10M24D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P2Y10M24D
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P2Y10M24D
CY2021 che Share Based Compensation Arrangement By Share Based Payment Award Expiration Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationYear
2023
CY2020 che Share Based Compensation Arrangement By Share Based Payment Award Expiration Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationYear
2022
CY2019 che Share Based Compensation Arrangement By Share Based Payment Award Expiration Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationYear
2021
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31420000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26802000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21338000
CY2021 che Share Based Compensation Arrangement By Share Based Payment Award Income Tax Benefit Recognized In Income
ShareBasedCompensationArrangementByShareBasedPaymentAwardIncomeTaxBenefitRecognizedInIncome
7918000
CY2020 che Share Based Compensation Arrangement By Share Based Payment Award Income Tax Benefit Recognized In Income
ShareBasedCompensationArrangementByShareBasedPaymentAwardIncomeTaxBenefitRecognizedInIncome
6904000
CY2019 che Share Based Compensation Arrangement By Share Based Payment Award Income Tax Benefit Recognized In Income
ShareBasedCompensationArrangementByShareBasedPaymentAwardIncomeTaxBenefitRecognizedInIncome
5373000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
62038000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
125448000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
106793000
CY2021 che Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalIntrinsicValue
1173000
CY2020 che Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalIntrinsicValue
1171000
CY2019 che Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalIntrinsicValue
767000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
482.66
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
466.43
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
331.69
CY2021Q4 che Stock Price On Date Of Issuance
StockPriceOnDateOfIssuance
445.35
CY2020Q4 che Stock Price On Date Of Issuance
StockPriceOnDateOfIssuance
471.74
CY2019Q4 che Stock Price On Date Of Issuance
StockPriceOnDateOfIssuance
413.19
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
96.91
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
97.56
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
78.06
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
326806
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
298670
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
287010
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y6M
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y6M
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0087
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0024
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0165
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2881
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2841
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2125
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.003
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.003
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.003
CY2021 us-gaap Net Income Loss
NetIncomeLoss
268550000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
319466000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
219923000
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
377000
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
757000
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
513000
CY2021 us-gaap Interest Expense
InterestExpense
1868000
CY2020 us-gaap Interest Expense
InterestExpense
2355000
CY2019 us-gaap Interest Expense
InterestExpense
4535000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
81764000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76524000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41686000
CY2021Q4 us-gaap Assets
Assets
1342723000
CY2020Q4 us-gaap Assets
Assets
1434911000
CY2019Q4 us-gaap Assets
Assets
1268317000
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
58856000
CY2020 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
61793000
CY2019 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
189024000
CY2021 che Depreciation Amortization Of Intangibles And Stock Award
DepreciationAmortizationOfIntangiblesAndStockAward
59051000
CY2020 che Depreciation Amortization Of Intangibles And Stock Award
DepreciationAmortizationOfIntangiblesAndStockAward
56583000
CY2019 che Depreciation Amortization Of Intangibles And Stock Award
DepreciationAmortizationOfIntangiblesAndStockAward
45205000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10000000.0
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10000000.0
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4300000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
10017000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
9963000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9916000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9902000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
9557000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2147000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
109150000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
57648000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
51502000
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
165744000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
57648000
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
108096000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
109150000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
47607000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
61543000
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
165692000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
47607000
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
118085000
CY2021Q4 che Payment Of Liabilities Discounted Operations Year One
PaymentOfLiabilitiesDiscountedOperationsYearOne
826000
CY2021Q4 che Payment Of Liabilities Discounted Operations Year Two
PaymentOfLiabilitiesDiscountedOperationsYearTwo
300000
CY2021Q4 che Payment Of Liabilities Discounted Operations Thereafter
PaymentOfLiabilitiesDiscountedOperationsThereafter
601000
CY2021Q4 che Total Estimated Timing Of Payments Of Liabilities Related To Discontinued Operations
TotalEstimatedTimingOfPaymentsOfLiabilitiesRelatedToDiscontinuedOperations
1727000
CY2021Q4 che Capitalized Property And Equipment Not Paid
CapitalizedPropertyAndEquipmentNotPaid
1900000
CY2020Q4 che Capitalized Property And Equipment Not Paid
CapitalizedPropertyAndEquipmentNotPaid
3900000
CY2019Q4 che Capitalized Property And Equipment Not Paid
CapitalizedPropertyAndEquipmentNotPaid
1800000
CY2021Q4 che Cash Overdraft Payable Included In Accounts Payable
CashOverdraftPayableIncludedInAccountsPayable
11900000
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
100000
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
100000
CY2021 che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
8310000
CY2020 che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
7933000
CY2019 che Market Value Gains On Assets Held In Deferred Compensation Trust
MarketValueGainsOnAssetsHeldInDeferredCompensationTrust
8254000
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
377000
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
757000
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
513000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
457000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9144000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8665000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8764000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
64620000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
58602000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
36779000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
14233000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
15950000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
7078000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
511000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
539000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
600000
CY2021 che Deferred Federal State And Local Income Tax Expense Benefit
DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
2358000
CY2020 che Deferred Federal State And Local Income Tax Expense Benefit
DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
1456000
CY2019 che Deferred Federal State And Local Income Tax Expense Benefit
DeferredFederalStateAndLocalIncomeTaxExpenseBenefit
-2773000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
42000
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-23000
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
2000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
81764000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76524000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41686000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
42840000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
42151000
CY2021Q4 che Deferred Tax Assets Tax Deferred Expense Lease Liabilities
DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities
35936000
CY2020Q4 che Deferred Tax Assets Tax Deferred Expense Lease Liabilities
DeferredTaxAssetsTaxDeferredExpenseLeaseLiabilities
35888000
CY2021Q4 che Deferred Tax Assets Implicit Price Concessions
DeferredTaxAssetsImplicitPriceConcessions
7744000
CY2020Q4 che Deferred Tax Assets Implicit Price Concessions
DeferredTaxAssetsImplicitPriceConcessions
7031000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6976000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4047000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1920000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2030000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
920000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
888000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
96336000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
92035000
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
41925000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
40619000
CY2021Q4 che Deferred Tax Liabilities Right Of Use Lease Assets
DeferredTaxLiabilitiesRightOfUseLeaseAssets
35416000
CY2020Q4 che Deferred Tax Liabilities Right Of Use Lease Assets
DeferredTaxLiabilitiesRightOfUseLeaseAssets
31686000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
32489000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
32788000
CY2021Q4 us-gaap Deferred Tax Liabilities Regulatory Assets
DeferredTaxLiabilitiesRegulatoryAssets
3858000
CY2020Q4 us-gaap Deferred Tax Liabilities Regulatory Assets
DeferredTaxLiabilitiesRegulatoryAssets
3921000
CY2021Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
3189000
CY2020Q4 us-gaap Deferred Tax Liabilities Investments
DeferredTaxLiabilitiesInvestments
2382000
CY2021Q4 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
2504000
CY2020Q4 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
1161000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
138000
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
142000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
119519000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
112699000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
23183000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
20664000
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
43900000
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
37300000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1304000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1323000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1348000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
333000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
200000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
234000
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
258000
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
219000
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
259000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1379000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1304000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1323000
CY2021Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
131000
CY2020Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
163000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
73566000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
83158000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
54938000
CY2021 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
9884000
CY2020 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
26089000
CY2019 us-gaap Income Tax Reconciliation Tax Credits Other
IncomeTaxReconciliationTaxCreditsOther
24177000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
10025000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
13855000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
7880000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
7443000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
5377000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
3048000
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
614000
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
223000
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-3000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
81764000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76524000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41686000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.193
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.159
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
99430000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
61517000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
44063000
CY2021Q4 us-gaap Undistributed Earnings Of Domestic Subsidiaries
UndistributedEarningsOfDomesticSubsidiaries
35100000
CY2021Q4 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Domestic Subsidiaries
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfDomesticSubsidiaries
8400000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
511591000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
481200000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
317911000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
293380000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193680000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
187820000
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
9000000.0
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
8900000
CY2021 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
5800000
CY2020 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
5500000
CY2019 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
4600000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
125048000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
123448000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37913000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
36200000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
100629000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
99210000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
138542000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
135410000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
61474000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
60195000
CY2021 us-gaap Sublease Income
SubleaseIncome
181000
CY2020 us-gaap Sublease Income
SubleaseIncome
83000
CY2021 us-gaap Lease Cost
LeaseCost
61293000
CY2020 us-gaap Lease Cost
LeaseCost
60112000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
50990000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
49932000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
52878000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
58802000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M9D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0241
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
42726000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
33700000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
25879000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
18596000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
11729000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
13950000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
146580000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8014000
CY2021Q4 che Lessee Operating Lease Future Lease Obligations Not Yet Commenced
LesseeOperatingLeaseFutureLeaseObligationsNotYetCommenced
24000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
138542000
CY2021 che Operating Lease Payments Include To Extended Lease Terms
OperatingLeasePaymentsIncludeToExtendedLeaseTerms
2000000.0
CY2021 che Lessee Operating Lease Lease Signed But Not Yet Commenced Payments
LesseeOperatingLeaseLeaseSignedButNotYetCommencedPayments
24000
CY2021 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
27332000
CY2020 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
27044000
CY2019 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
25529000
CY2021Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
65663
CY2021Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
2200000
CY2020Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
74262
CY2020Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
2300000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15938000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
268550000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15671000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
17.14
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
221000
CY2021 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
46000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
268550000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
16.85
CY2020 us-gaap Net Income Loss
NetIncomeLoss
319466000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15955000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
20.02
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
368000
CY2020 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
75000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
319466000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16398000
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
19.48
CY2019 us-gaap Net Income Loss
NetIncomeLoss
219923000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15969000
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
13.77
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
480000
CY2019 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
78000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
219923000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16527000
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
13.31
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
617000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
566000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
287000
CY2019 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-9132000
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
576483000
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
175594000
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
92631000
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1195529
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
384252
CY2019 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
269009
CY2021 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
482.20
CY2020 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
456.98
CY2019 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
344.34
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
600000000.0
CY2021Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
201900000
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-987000
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
75095000

Files In Submission

Name View Source Status
0001562762-22-000060-index-headers.html Edgar Link pending
0001562762-22-000060-index.html Edgar Link pending
0001562762-22-000060.txt Edgar Link pending
0001562762-22-000060-xbrl.zip Edgar Link pending
che-20211231.xsd Edgar Link pending
che-20211231x10k.htm Edgar Link pending
che-20211231x10kg001.jpg Edgar Link pending
che-20211231x10k_htm.xml Edgar Link completed
che-20211231xex10_19.htm Edgar Link pending
che-20211231xex10_20.htm Edgar Link pending
che-20211231xex21.htm Edgar Link pending
che-20211231xex23.htm Edgar Link pending
che-20211231xex24.htm Edgar Link pending
che-20211231xex31_1.htm Edgar Link pending
che-20211231xex31_2.htm Edgar Link pending
che-20211231xex31_3.htm Edgar Link pending
che-20211231xex32_1.htm Edgar Link pending
che-20211231xex32_2.htm Edgar Link pending
che-20211231xex32_3.htm Edgar Link pending
che-20211231_cal.xml Edgar Link unprocessable
che-20211231_def.xml Edgar Link unprocessable
che-20211231_lab.xml Edgar Link unprocessable
che-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending